Cargando…

CARM1 and BAF155: an example of how chromatin remodeling factors can be relocalized and contribute to cancer

In a recent article, Wang and colleagues reported the discovery of a mechanism by which CARM1 regulates the genomic localization of BAF155 (a SWI/SNF subunit involved in chromatin remodeling) through post-translational methylation at R1064 arginine residues. This modification leads to the relocaliza...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefansson, Olafur A, Esteller, Manel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053224/
https://www.ncbi.nlm.nih.gov/pubmed/25927994
http://dx.doi.org/10.1186/bcr3657
_version_ 1782320337784930304
author Stefansson, Olafur A
Esteller, Manel
author_facet Stefansson, Olafur A
Esteller, Manel
author_sort Stefansson, Olafur A
collection PubMed
description In a recent article, Wang and colleagues reported the discovery of a mechanism by which CARM1 regulates the genomic localization of BAF155 (a SWI/SNF subunit involved in chromatin remodeling) through post-translational methylation at R1064 arginine residues. This modification leads to the relocalization of BAF155-containing SWI/SNF complexes to regions containing genes involved in the Myc oncogenic pathway. The results presented are evidence that these interactions constitute a mechanism by which the BAF155 chromatin remodeling factor contributes to cancer.
format Online
Article
Text
id pubmed-4053224
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40532242014-11-19 CARM1 and BAF155: an example of how chromatin remodeling factors can be relocalized and contribute to cancer Stefansson, Olafur A Esteller, Manel Breast Cancer Res Viewpoint In a recent article, Wang and colleagues reported the discovery of a mechanism by which CARM1 regulates the genomic localization of BAF155 (a SWI/SNF subunit involved in chromatin remodeling) through post-translational methylation at R1064 arginine residues. This modification leads to the relocalization of BAF155-containing SWI/SNF complexes to regions containing genes involved in the Myc oncogenic pathway. The results presented are evidence that these interactions constitute a mechanism by which the BAF155 chromatin remodeling factor contributes to cancer. BioMed Central 2014 2014-05-19 /pmc/articles/PMC4053224/ /pubmed/25927994 http://dx.doi.org/10.1186/bcr3657 Text en Copyright © 2014 Esteller and Stefansson; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 The licensee has exclusive rights to distribute this article, in any medium, for 12 months following its publication. After this time, the article is available under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Viewpoint
Stefansson, Olafur A
Esteller, Manel
CARM1 and BAF155: an example of how chromatin remodeling factors can be relocalized and contribute to cancer
title CARM1 and BAF155: an example of how chromatin remodeling factors can be relocalized and contribute to cancer
title_full CARM1 and BAF155: an example of how chromatin remodeling factors can be relocalized and contribute to cancer
title_fullStr CARM1 and BAF155: an example of how chromatin remodeling factors can be relocalized and contribute to cancer
title_full_unstemmed CARM1 and BAF155: an example of how chromatin remodeling factors can be relocalized and contribute to cancer
title_short CARM1 and BAF155: an example of how chromatin remodeling factors can be relocalized and contribute to cancer
title_sort carm1 and baf155: an example of how chromatin remodeling factors can be relocalized and contribute to cancer
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053224/
https://www.ncbi.nlm.nih.gov/pubmed/25927994
http://dx.doi.org/10.1186/bcr3657
work_keys_str_mv AT stefanssonolafura carm1andbaf155anexampleofhowchromatinremodelingfactorscanberelocalizedandcontributetocancer
AT estellermanel carm1andbaf155anexampleofhowchromatinremodelingfactorscanberelocalizedandcontributetocancer